Luminescence spectroscopy as a screening tool for the potential carcinogenicity of asphalt fumes.
A subset of polycyclic aromatic compounds (PACs), which contain 4-6 annulated rings, has been documented as the source of carcinogenicity in animal skin painting studies of petroleum products and asphalt fumes (M. L. Machado, P. W. Beatty, J. C. Fetzer, A. H. Glickman and E. L. McGinnis, Fundam. Appl. Toxicol., 1993, 21, 492; T. A. Roy, S. W. Johnson, G. R. Blackburn and C. R. Mackerer, Fundam. Appl. Toxicol., 1988, 10, 466). Because of the chemical complexity of these materials, it has been difficult to identify the specific compounds within this broad range of PACs responsible for their carcinogenicity. An alternative approach using luminescence spectroscopy was taken in this study to quantify, without identification, a subset of these compounds that appears to cause cancer. The fluorescence response at a specific wavelength pair was obtained for 39 laboratory asphalt fume condensates from animal skin painting studies, yielding a linear correlation coefficient of R2 = 0.96 between the fluorescence response in these materials and the carcinogenicity found in animal studies. In the absence of other asphalt fume condensates from animal studies, 17 petroleum oils were also evaluated using this method and compared with the available animal skin painting data. The details of the method include a clean-up step that removes the highly polar compounds and spectral subtraction of two- and three-ring PAC interference, both of which add to the fluorescence response, yet were not found to contribute to a carcinogenic response from skin painting studies. Full scan fluorescence plots also produce a fingerprint which can be used to assess contamination, such as coal tar products or mixtures of materials, that are not defined as asphalt, yet may be present in the working environment.
Osborn
L V
LV
Heritage Research Group, 7901 West Morris Street, Indianapolis, IN 46231, USA.
Kurek
J T
JT
Kriech
A J
AJ
Fehsenfeld
F M
FM
D000393:Air Pollutants / Q000009:adverse effects*; D000818:Animals; D001681:Biological Assay / Q000379:methods; D002273:Carcinogens / Q000009:adverse effects*; D004353:Drug Evaluation, Preclinical / Q000379:methods; D005453:Fluorescence; D006838:Hydrocarbons / Q000009:adverse effects*; D011084:Polycyclic Aromatic Hydrocarbons / Q000009:adverse effects*; D012377:Rodentia; D012867:Skin / Q000187:drug effects; D014835:Volatilization
D000393:Air Pollutants; D002273:Carcinogens; D006838:Hydrocarbons; D011084:Polycyclic Aromatic Hydrocarbons; C006647:asphalt